These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21877459)

  • 21. Drug dosing guidelines in patients with renal failure.
    Swan SK; Bennett WM
    West J Med; 1992 Jun; 156(6):633-8. PubMed ID: 1615656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The treatment of arterial hypertension in diabetes mellitus. Choices and problems].
    Orsini S; Allegri L; Castiglioni A; Garini G; Vinci S; Savazzi G
    Recenti Prog Med; 1993 Dec; 84(12):873-83. PubMed ID: 8108603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in the use of antihypertensive drugs by outpatients with diabetes in Taiwan, 1997-2003.
    Chiang CW; Chen CY; Chiu HF; Wu HL; Yang CY
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):412-21. PubMed ID: 17252613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [May medical therapy of arterial hypertension by used in patients with renal failure?].
    Richet G; Ducrot H; Hamburger J; Legrain M; Maxwell M; Péquignot MH
    Presse Med (1893); 1968 Nov; 76(44):2103-6. PubMed ID: 5701039
    [No Abstract]   [Full Text] [Related]  

  • 25. The renoprotective effects of RAS inhibition: focus on prevention and treatment of chronic kidney disease.
    Weir MR
    Postgrad Med; 2009 Jan; 121(1):96-103. PubMed ID: 19179817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with control of hypertension, hypercholesterolemia, and diabetes among low-income women in West Virginia.
    Ahluwalia IB; Tessaro I; Greenlund KJ; Ford ES
    J Womens Health (Larchmt); 2010 Mar; 19(3):417-24. PubMed ID: 20156080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease.
    Snyder RW; Berns JS
    Semin Dial; 2004; 17(5):365-70. PubMed ID: 15461745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selected pharmacokinetic issues in patients with chronic kidney disease.
    Churchwell MD; Mueller BA
    Blood Purif; 2007; 25(1):133-8. PubMed ID: 17170551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethical considerations in cardiovascular prevention.
    Follath F
    Fundam Clin Pharmacol; 2009 Dec; 23(6):669-73. PubMed ID: 19500153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug therapy of hyperglycemia and the prognosis of adult-onset diabetes mellitus].
    Niskanen L; Uusitupa M; Laakso M
    Duodecim; 1999; 115(10):1122-4. PubMed ID: 11877851
    [No Abstract]   [Full Text] [Related]  

  • 31. Renal considerations in cardiovascular drug therapy.
    Feinfeld DA; Frishman WH
    Cardiol Clin; 1987 Nov; 5(4):675-88. PubMed ID: 3331320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hypertension in hemodialysis patients in Andalucia].
    García Cortés MJ; Ceballos M;
    Nefrologia; 2004; 24(2):149-57. PubMed ID: 15219090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis provider.
    Manley HJ; Garvin CG; Drayer DK; Reid GM; Bender WL; Neufeld TK; Hebbar S; Muther RS
    Nephrol Dial Transplant; 2004 Jul; 19(7):1842-8. PubMed ID: 15128886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preferential adherence to immunosuppressive over nonimmunosuppressive medications in kidney transplant recipients.
    Terebelo S; Markell M
    Transplant Proc; 2010 Nov; 42(9):3578-85. PubMed ID: 21094819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of antitubercular medications on blood pressure control in chronic kidney disease patients with tuberculosis: a prospective cohort study.
    Sharma AP; Sural S; Gupta A; Garg AX; Gulati S; Sharma RK
    J Nephrol; 2006; 19(6):771-7. PubMed ID: 17173251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of baseline cardiovascular risk factors in the SU-FOL-OM3 study cohort: does the localization of the arterial event matter?
    Vesin C; Galan P; Gautier B; Czernichow S; Hercberg S; Blacher J
    Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):541-8. PubMed ID: 20216318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with medication-related problems in ambulatory hemodialysis patients.
    Manley HJ; McClaran ML; Overbay DK; Wright MA; Reid GM; Bender WL; Neufeld TK; Hebbar S; Muther RS
    Am J Kidney Dis; 2003 Feb; 41(2):386-93. PubMed ID: 12552501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [CME: Antidiabetics in renal failure and kidney transplantation].
    Seer C; Lehmann R
    Praxis (Bern 1994); 2016 Jan; 105(2):69-74; quiz 75-6. PubMed ID: 26787327
    [No Abstract]   [Full Text] [Related]  

  • 39. [The kidney as a target organ in diabetic patients with arterial hypertension].
    Viberti G
    Drugs; 2003; 63 Spec No 1():31-7. PubMed ID: 12708880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Urapidil (Ebrantil) use in patients on chronic hemodialysis].
    Krawczyk W; Steć E
    Wiad Lek; 1990 Jun; 43(11):501-5. PubMed ID: 2219915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.